Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries-Reference-Cited by-同舟云学术

Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries

Published:2021-06 Issue: Volume:51 Page:102879
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Viktoria Papp,Trones Kim D.P.,Magyari Melinda,Koch-Henriksen Nils,Iljicsov Anna^ORCID,Rajda Cecilia^ORCID,Nielsen Helle H.,Lovas Gabor,Rozsa Csilla,Kristiansen Bjørn H.,Stenager Egon,Frederiksen Jette L.^ORCID,Komoly Samuel,Sellebjerg Finn^ORCID,Petersen Thor,Illes Zsolt

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference36 articles.

1. Revised diagnostic criteria for neuromyelitis optica;Wingerchuk;Neurology,2006

2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders;Wingerchuk;Neurology,2015

3. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients;Hamid;J Neurol,2017

4. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes;Juryńczyk;J Neurol,2016

5. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan;Kitley;Brain,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis;Journal of Neurology;2024-07-03

2. Neuromyelitis optica spectrum disorder co‐existing with antiphospholipid syndrome: A case report;Clinical Case Reports;2024-05

3. Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia;Multiple Sclerosis and Related Disorders;2024-05

4. Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders;Frontiers in Immunology;2022-02-18

5. Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges;Autoimmunity Reviews;2022-01